InvestSMART

EBR Systems Inc (ASX: EBR) - Share Price

Current share price for EBR : $0.150 0.015 (9.09%)+

EBR Systems Inc (EBR) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is dedicated to treatment of cardiac rhythm disease by providing physiologically effective stimulation through wireless cardiac pacing. The patented proprietary Wireless Stimulation Endocardially (WiSE) technology was developed to eliminate the need for cardiac pacing leads, historically the source of complications, effectiveness and reliability issues in cardiac rhythm disease management.

EBR General Information +

ASX Code EBR
Website N/A
Industry/Sector Health Care Equipment
Market Cap ($M) 126
EBR Share Price $0.150
Day High $0.165
Day Low $0.145
Last Close $0.165
EBR Share Price Movement $0.02 ( 9.09% )
Prices as at 16:40, 18 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

EBR Systems Inc (EBR) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from EBR Systems Inc (EBR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

EBR Systems Inc (EBR) price-sensitive announcements

EBR - Q3 2026 Quarterly Activity Report and Form 10-Q Submission
EBR Systems’ Q3 2026 Quarterly Activity Report and Form 10-Q submission reported continued
EBR Systems Inc (EBR)
10 Nov 2026 | 8:25 AM
EBR - EBR Submits TGA ARTG Application for WiSE System
EBR Systems, Inc. announced that it has formally submitted an application to the Therapeut
EBR Systems Inc (EBR)
20 Oct 2026 | 9:00 AM
EBR - Q3 2026 Commercial Update
EBR Systems’ Q3 2026 Commercial Update reported 40 WiSE commercial implants for the quarte
EBR Systems Inc (EBR)
12 Oct 2026 | 9:01 AM
EBR - CMS Finalises Increased Inpatient Reimbursement for WiSE
EBR Systems, Inc. announced that the U.S. Centers for Medicare & Medicaid Services (CMS) h
EBR Systems Inc (EBR)
21 Sep 2026 | 9:07 AM

EBR Systems Inc (EBR) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
EBR Systems Inc (EBR)
CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB
Health Care $127 Change of Director's Interest Notice 16 Nov 2026 1:27PM $0.155 $0.150 fallen by 3.23%
EBR Systems Inc (EBR)
CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB
Health Care $127 Customers Notification - Updated Ultrasound Precautions 12 Nov 2026 8:24AM $0.170 $0.150 fallen by 11.76%
EBR Systems Inc (EBR)
CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB
Health Care $127 Investor Webinar - Updated 10 Nov 2026 10:58AM $0.155 $0.150 fallen by 3.23%
EBR Systems Inc (EBR)
CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB
Health Care $127 Investor Webinar 10 Nov 2026 8:31AM $0.135 $0.150 risen by 11.11%
EBR Systems Inc (EBR)
CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB
Health Care $127 Q3 2026 Quarterly Activity Report and Form 10-Q Submission 10 Nov 2026 8:25AM $0.135 $0.150 risen by 11.11%
EBR Systems Inc (EBR)
CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB
Health Care $127 EBR to Present at Canaccord Genuity Forum 3 Nov 2026 10:38AM $0.113 $0.150 risen by 33.33%

EBR Financial Summary

Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$72.85 -$16.30 -13.50% 0.00 0.00 0.00% 0.0%
2024A -$65.62 -$18.90 14.80% 0.00 0.00 0.00% 0.0%
2023A -$51.22 -$16.50 -2.10% 0.00 0.00 0.00% 0.0%

EBR Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Cochlear Limited (COH) $9,864M -0.3136 0.2540 0.0785 36.7206 29.2828 27.1516 2.29% 2.38% 2.59%
EBR Systems Inc (EBR) $131M -0.1354 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Fisher & Paykel Healthcare Corporation Limited (FPH) $23,272M 0.1388 0.1465 0.1573 59.8216 52.1762 45.0826 1.10% 1.19% 1.32%
Imricor Medical Systems Inc (IMR) $482M -0.4254 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed Inc. (RMD) $19,693M 9.5922 0.1126 0.0881 22.8557 20.5427 18.8801 1.02% 1.08% 1.16%

EBR Directors

Name Position Start Date
Mr John Graham McCutcheon Chief Executive Officer, President, Executive Director 17 Jun 2019
Mr Allan Roger Will Executive Chairman, Executive Director 9 May 2003
Dr Christopher Dean Nave Non-Executive Director 30 Oct 2017
Ms Karen Ruth Drexler Non-Executive Director 1 Oct 2021
Dr Bronwyn Joy Evans Non-Executive Director 1 Oct 2021
Dr David Mark Steinhaus Non-Executive Director 1 Oct 2021
Mr Trevor John Moody Non-Executive Director 30 Oct 2017

EBR Systems Inc (EBR) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
13 Nov 2026 EVANS, Bronwyn Buy Indirect Shares 474,878 $0.163 $77,446.420
12 Nov 2026 EVANS, Bronwyn Buy Indirect Shares 97,752 $0.165 $16,149.030
29 Jun 2026 EVANS, Bronwyn Issued Indirect Shares 275,790 $0.380 $104,800.200

See all changes in directors' interest & trades for EBR Systems Inc (EBR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EBR Management

Name Position
Eric Strandberg Chief Commercial Officer
Andrew Shute Chief Corporate Development Officer
Gary William Doherty Chief Financial Officer
Spencer H. Kubo Chief Medical Officer
Michael Hendricksen Chief Operating Officer
Pharoah Garma Chief Regulatory Officer
N. Parker Willis Chief Technology Officer
Zheng(Kobe) Li Company Secretary
Philip Hale Oettinger Unites States Company Secretary

EBR Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EBR Systems Inc (EBR). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
42,795,906 (9.50%) Host Plus Pty Limited
41,056,191 (9.11%) Carnegie Group
33,509,252 (7.44%) H.E.S.T. Australia Limited
26,728,931 (5.93%) Split Rock Partners, LP

EBR Calendar of Events

Date Event
11 May 2027 Report (Quarterly)
30 March 2027 Report (Annual)
26 March 2027 Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.